Tumour suppressors, kinases and clamps: How p53 regulates the cell cycle in response to DNA damage

BioEssays

Volumn 17, Issue 6, 1995, Pages 501-508

  Cox, Lynne S ^a   Lane, David P ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; DNA DIRECTED DNA POLYMERASE; DNA DIRECTED DNA POLYMERASE GAMMA; PROTEIN KINASE; PROTEIN P53;

ALTERNATIVE RNA SPLICING; BIOSYNTHESIS; CELL CYCLE; CELL CYCLE G1 PHASE; DNA DAMAGE; DNA REPAIR; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HOMEOSTASIS; HUMAN; METABOLISM; ONCOGENE; OXIDATION REDUCTION REACTION; PHOSPHORYLATION; REVIEW; RNA TRANSLATION; TRANSACTIVATION; TUMOR SUPPRESSOR GENE;

ALTERNATIVE SPLICING; CELL CYCLE; DNA DAMAGE; DNA POLYMERASE III; DNA REPAIR; DNA-DIRECTED DNA POLYMERASE; G1 PHASE; GENES, P53; GENES, TUMOR SUPPRESSOR; HOMEOSTASIS; HUMAN; ONCOGENES; OXIDATION-REDUCTION; PHOSPHORYLATION; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTEIN KINASES; PROTEIN P53; SUPPORT, NON-U.S. GOV'T; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION, GENETIC; TRANSFECTION; TRANSLATION, GENETIC;

EID: 0029315510     PISSN: 02659247     EISSN: 15211878     Source Type: Journal    
DOI: 10.1002/bies.950170606     Document Type: Review

References (98)

1. Structural aspects of the p53 protein in relation to gene evolution
2. p53 mutations in human cancers
3. UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells
4. Participation of p53 in the cellular response to DNA damage
5. Differential induction of transcriptionally active p53 following UV or ionizing radiation: defects in chromosome instability syndromes?
6. p53 expression in cultured cells following radioisotope labelling
7. p53‐dependent growth arrest following calcium phosphate‐mediated transfection of murine fibroblasts
8. Growth regulation of a cellular tumour antigen, p53, in nontransformed cells
9. Expression of wild‐type p53 during the cell cycle in normal human mammary epithelial cells
10. Mice deficient for p53 are developmentaly normal but susceptible to spontaneous tumours
11. Stabilization and expression of high levels of p53 during early development in Xenopus laevis
12. Overexpression of wild‐type p53 interferes with normal development in Xenopus laevis embryos
13. Xenopus p53 is biochemically similar to the human tumour suppressor protein p53 and is induced upon DNA damage in somatic cells
14. Wild‐type human p53 is antiproliferative in SV40‐transformed hamster cells
15. Conditional inhibition of transformation and of cell proliferation by a temperature‐sensitive mutant of p53
16. Cellular localization and cell cycle regulation by a temperature‐sensitive p53 protein
17. Sequence‐specific transcriptional activation is essential for growth suppression by p53
18. Transcriptional activation by p53 correlates with suppression of growth but not transformation
19. Identification of a minimal transforming domain of p53: Negative dominance through abrogation of sequence‐specific DNA binding
20. Participation of p53 protein in the cellular response to DNA damage
21. High levels of p53 protein in UV‐irradiated normal human skin
22. DNA strand breaks: the DNA template alterations that trigger p53‐dependent DNA damage response pathways
23. Ionizing radiation and UV induction of p53 protein by different pathways in ataxia‐telangiectasia cells
24. Ionizing radiation and cell cycle progression in ataxia telangiectasia
25. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in Ataxia‐Telengiectasia
26. Guanine nucleotide biosynthesis is regulated by the cellular p53 concentration
27. Cell cycle arrest and radiosensitivity of human tumor cell lines: dependence on wild‐type p53 for radiosensitivity
28. Indistinct cell cycle checkpoint after u.v. damage in H‐ras‐transformed mouse liver cells despite normal p53 gene expression
29. Cells expressing HPV16 E7 continue cell cycle progression following DNA damage induced p53 activation
30. 1 arrest involves pRB‐related proteins and is disrupted by the human papillomavirus 16 E7oncoprotein
31. Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7
32. Ras‐induced hyperplasia occurs with mutation of p53, but activated ras and myc together can induce carcinoma without p53 mutation
33. p53‐catalyzed annealing of complementary single‐stranded nucleic acids
34. Human p53 directs DNA strand reassociation and is photolabelled by 8‐azido ATP
35. Inhibition of DNA replication factor RPA by p53
36. A direct effect of activated human p53 on eukaryotic DNA replication
37. 2/M by p53
38. Radiation‐induced irreversible G(0)/G(1) block is abolished in human diploid fibroblasts transfected with the human papilloma virus E6 gene
39. p53 transcriptional activation mediated by coactivators TAFII40 and TAFII60
40. Cooperative DNA binding of p53 with TFIID (TBP): a possible mechanism for transcriptional activation
41. Inhibition of viral and cellular promoters by human wild‐type p53
42. Transcriptional regulation of the PCNA promoter by p53
43. Repression of the basal c‐fos promoter by wild‐type p53
44. Definition of a consensus binding site for p53
45. The transcriptional transactivation function of wild‐type p53 is inhibited by SV40 large T antigen and by HPV‐16 E6 oncoprotein
46. WAF‐1, a potential mediator of p53 tumour suppression
47. 1 cyclin‐dependent kinases
48. p21 is a universal inhibitor of cyclin kinases
49. Inhibition of Cdk2 activity in vivo by an associated 20K regulatory subunit
50. Cloning of senescent cell‐derived inhibitors of DNA synthesis using an expression screen
51. D‐type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA
52. p21‐containing cyclin kinases exist in both active and inactive states
53. 1 arrest
54. Mechanisms of regulation of WAF1/Cip1 gene expression in human breast carcinoma: role of p53‐dependent and independent signal transduction pathways
55. The p21 inhibitor of cyclin‐dependent kinases controls DNA replication by interaction with PCNA
56. WAF1 and proliferating cell nuclear antigen
57. Differential effects by the p21 CDK inhibitor on PCNA‐dependent DNA replication and repair
58. Cip1 inhibits DNA replication but not PCNA‐dependent nucleotide excision repair
59. Molecular cloning, sequencing, chromosomal localization and expression of mouse p21 (Waf1)
60. SDI1/CIP1/WAF1
61. Cyclin G is a transcriptional target of the p53 tumour suppressor protein
62. p53‐dependent apoptosis in the absence of transcriptional activation of p53‐target genes
63. Hepatitis B virus X protein inhibits p53 sequence‐specific DNA binding, transcriptional activity, and association with transcription factor ERCC3
64. The p53‐dependent gamma‐ray response of GADD45
65. Interaction of the p53‐regulated protein Gadd45 with proliferating cell nuclear antigen
66. Mdm2 expression is induced by wild type p53 activity
67. Wild type p53 can mediate sequence‐specific transactivation of an internal promoter within the Mdm2 gene
68. Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway
69. Immunochemical analysis of the interaction of p53 with MDM2; fine mapping of the MDM2 binding site on p53 using synthetic peptides
70. The mdm‐2 oncogene product forms a complex with the p53 protein and inhibits p53‐mediated transactivation
71. The mdm‐2 gene is induced in response to UV light in a p53‐dependent manner
72. Endogenous p53 protein generated from wild‐type alternately spliced p53 RNA in mouse epidermal cells
73. Increase in p53 protein half‐life in mouse keratinocytes following UV‐E irradiation
74. Nuclear protein phosphorylation and growth control
75. Activation of the cryptic DNA binding function of mutant forms of p53
76. Human wild‐type p53 adopts a unique conformational and phosphorylation state in vivo during growth arrest of glioblastoma cells
77. Mutation of the casein kinase II phosphorylation site abolishes the anti‐proliferative activity of p53
78. The carboxy‐terminal serine 392 phosphorylation site of human p53 is not required for wild‐type activities
79. Human cells contain a DNA‐activated protein kinase that phosphorylates Simian Virus 40 T antigen, mouse p53, and the human Ku autoantigen
80. Mutation of the serine 15 phosphorylation site of human p53 reduces the ability of p53 to inhibit cell cycle progression
81. Redox regulation of fos and jun DNA‐binding activity in vitro
82. Identification of cellular proteins that bind the central conserved region of p53
83. Two cellular proteins that bind to wild‐type but not mutant p53
84. Nuclear localization is essential for the activity of p53 protein
85. Subcellular distribution of the p53 protein during the cell cycle of Balb/c 3T3 cells
86. c‐myc and bcl‐2 modulate p53 function by altering p53 subcellular trafficking during the cell cycle
87. Localization of p53, retinoblastoma and host replication proteins at sites of viral replication in herpes‐infected cells
88. Protein synthesis is required to anchor a mutant p53 protein which is temperature‐sensitive for nuclear transport
89. The p53 nuclear localisation signal is structurally linked to a p34cdc2 kinase motif
90. Tumor suppressor p53 is a regulator of bcl‐2 and bax gene expression in vitro and in vivo
91. Immediate early up‐regulation of bax expression by p53 but not TGF beta 1: a paradigm for distinct apoptotic pathways
92. p53 and E2F‐1 cooperate to mediate apoptosis
93. p53‐dependent apoptosis suppresses tumor growth and progression in vivo
94. p53 mutations increase resistance to ionising radiation
95. p53, guardian of the genome
96. Crystal structure of a p53 tumor suppressor‐DNA complex: understanding tumorigenic mutations